CVS Health Hold Rating Justified by Guidance Reduction and U

CVS Health Hold Rating Justified by Guidance Reduction and Uncertain Cost Trends

Analyst Steve Baxter of Wells Fargo maintained a Hold rating on CVS Health (CVS – Research Report), retaining the price target of $76.00. ...

Related Keywords

Steve Baxter , Wells Fargo , Barclays , Analyst Steve Baxter , Research Report , Medicare Advantage , Tipranks Premium ,

© 2025 Vimarsana